Reimagining Alzheimer’s (Part 5): Setback For Potential Alzheimer’s Treatment

In the last installment of this series, I discussed a promising treatment for Alzheimer’s disease called lecanemab. Here, I describe a recent setback for lecanemab’s clinical trials and introduce other potential treatments for Alzheimer’s that are currently underway.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive